GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Progenics Pharmaceuticals Inc. (PGNX) [hlAlert]

Rating:
Buy PGNX
up 53.52 %

Progenics Pharmaceuticals Inc. (PGNX) upgraded to Buy with price target $8 by Needham

Posted on: Monday,  Feb 3, 2014  8:25 AM ET by Needham

Needham rated Buy Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) on 02/03/2014, when the stock price was $5.10. Since
then, Progenics Pharmaceuticals Inc. has gained 53.53% as of 01/22/2016's recent price of $7.83.
If you would have followed this Needham's recommendation on PGNX, you would have gained 53.52% of your investment in 718 days.

Progenics Pharmaceuticals, Inc. is a biopharmaceutical company focusing on the development & commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward symptom management and supportive care and the treatment of HIV infection and cancer. The Company has four product candidates in clinical development and several others in preclinical development. The Company in collaboration with Wyeth, is developing methylnaltrexone for the treatment of opioid-induced side effects, including constipation and post-operative ileus. In the area of HIV infection, the Company is developing the viral-entry inhibitor PRO one hundred forty, a humanized monoclonal antibody targeting the HIV coreceptor CCR5. In addition, the Company is conducting research on ProVax, a novel prophylactic HIV vaccine.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/3/2014 8:25 AM Buy
None
5.10 8.00
as of 10/17/2014
1 Week up  4.23 %
1 Month down  -12.03 %
3 Months up  4.00 %
1 YTD down  -8.23 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/30/2012 10:25 AM Hold
None
5.80
10/14/2009 2:25 PM Hold
None
5.06

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy